Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 24.01%267.41M | 16.45%310.81M | 7.82%348.01M | 15.21%1.05B | -0.96%242.78M | 5.98%215.64M | 19.48%266.91M | 35.77%322.76M | -6.63%909.71M | 9.00%245.12M |
| Cost of revenue | 11.00%193.08M | 13.94%229.02M | 5.44%263.85M | 15.22%805.65M | -6.70%179.37M | 12.03%173.94M | 21.73%201M | 34.13%250.24M | -8.28%699.2M | 8.63%192.25M |
| Gross profit | 78.26%74.33M | 24.10%81.79M | 16.04%84.15M | 15.16%242.43M | 19.93%63.41M | -13.52%41.7M | 13.12%65.9M | 41.74%72.52M | -0.71%210.51M | 10.37%52.88M |
| Operating expense | 25.14%37.84M | 20.21%40.35M | 6.53%41.72M | 9.35%145.53M | 4.83%39.59M | 2.97%30.24M | 6.86%33.57M | 25.65%39.16M | 14.61%133.09M | 13.35%37.77M |
| Selling and administrative expenses | 15.72%38.27M | 22.16%42.81M | 12.31%41.85M | 9.35%145.53M | 8.16%40.14M | 5.30%33.07M | 6.74%35.05M | 17.43%37.26M | 14.61%133.09M | 34.37%37.11M |
| -Selling and marketing expense | 25.11%29.7M | 20.06%32M | 11.61%32.45M | 7.97%109.41M | 10.35%29.94M | -2.03%23.74M | 5.51%26.65M | 17.69%29.08M | 17.15%101.33M | 36.60%27.13M |
| -General and administrative expense | -8.14%8.58M | 28.82%10.81M | 14.80%9.4M | 13.75%36.12M | 2.21%10.2M | 30.06%9.34M | 10.84%8.39M | 16.53%8.18M | 7.18%31.75M | 28.64%9.98M |
| Other operating expenses | --471K | ---- | -55.48%1.73M | 0.08%2.44M | -85.19%265K | ---- | ---- | 246.35%3.89M | --2.44M | --1.79M |
| Total other operating income | -68.15%902K | 66.37%2.46M | -6.40%1.86M | 11.96%6.5M | -27.98%816K | 38.89%2.83M | 3.93%1.48M | 17.87%1.99M | --5.81M | --1.13M |
| Operating profit | 218.52%36.49M | 28.14%41.44M | 27.21%42.43M | 25.15%96.9M | 57.68%23.82M | -39.21%11.46M | 20.43%32.34M | 66.83%33.36M | -19.26%77.43M | 3.57%15.11M |
| Net non-operating interest income (expenses) | -22.90%-4.7M | -16.78%-4.44M | -12.73%-4.35M | -13.80%-15.68M | -21.48%-4.2M | -7.23%-3.83M | -12.25%-3.8M | -14.42%-3.86M | -40.37%-13.78M | -20.22%-3.45M |
| Non-operating interest expense | 22.90%4.7M | 16.78%4.44M | 12.73%4.35M | 6.10%11.02M | 21.48%4.2M | 7.23%3.83M | 12.25%3.8M | 14.42%3.86M | 14.55%10.39M | 62.77%3.45M |
| Total other finance cost | ---- | ---- | ---- | 37.35%4.66M | ---- | ---- | ---- | ---- | 352.06%3.4M | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 78.01%-104K | -927.27%-182K | 71.70%-15K | -1,117.54%-580K | -683.33%-70K | -1,851.85%-473K | 1,000.00%22K | -431.25%-53K | 104.71%57K | 100.99%12K |
| Less:Write off | -78.01%104K | 927.27%182K | -71.70%15K | 1,117.54%580K | 683.33%70K | 1,851.85%473K | -1,000.00%-22K | 431.25%53K | -104.71%-57K | -100.99%-12K |
| Other non-operating income (expenses) | 21.07%4.08M | -48.15%3.37M | ||||||||
| Income before tax | 342.71%31.68M | 28.92%36.82M | 29.29%38.07M | 26.31%84.72M | 67.64%19.56M | -53.24%7.16M | 21.70%28.56M | 76.96%29.45M | -26.59%67.07M | -31.39%11.67M |
| Income tax | 5,844.68%8.38M | 36.95%10.72M | 22.52%9.43M | 28.59%23.05M | 94.03%7.38M | -96.90%141K | 39.85%7.83M | 93.47%7.7M | -25.03%17.93M | -37.14%3.8M |
| Net income | 232.12%23.3M | 25.89%26.1M | 31.68%28.63M | 25.48%61.67M | 54.87%12.18M | -34.79%7.02M | 16.02%20.73M | 71.78%21.75M | -27.14%49.15M | -28.21%7.86M |
| Net income continuous operations | 232.12%23.3M | 25.89%26.1M | 31.68%28.63M | 25.48%61.67M | 54.87%12.18M | -34.79%7.02M | 16.02%20.73M | 71.78%21.75M | -27.14%49.15M | -28.21%7.86M |
| Noncontrolling interests | 2,445.16%789K | 11.03%946K | -2.47%789K | -20.15%2.17M | -4.75%481K | -94.58%31K | -0.23%852K | 2.53%809K | 75.48%2.72M | -43.58%505K |
| Net income attributable to the company | 222.29%22.51M | 26.52%25.15M | 33.00%27.85M | 28.15%59.5M | 58.96%11.7M | -31.44%6.98M | 16.83%19.88M | 76.38%20.94M | -29.55%46.43M | -26.85%7.36M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 222.29%22.51M | 26.52%25.15M | 33.00%27.85M | 28.15%59.5M | 58.96%11.7M | -31.44%6.98M | 16.83%19.88M | 76.38%20.94M | -29.55%46.43M | -26.85%7.36M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 222.22%0.1624 | 26.57%0.1815 | 32.96%0.2009 | 28.15%0.4293 | 58.95%0.0844 | -31.43%0.0504 | 16.78%0.1434 | 76.52%0.1511 | -29.55%0.335 | -26.76%0.0531 |
| Diluted earnings per share | 222.22%0.1624 | 26.57%0.1815 | 32.96%0.2009 | 28.15%0.4293 | 58.95%0.0844 | -31.43%0.0504 | 16.78%0.1434 | 76.52%0.1511 | -29.55%0.335 | -26.76%0.0531 |
| Dividend per share | 0 | -37.50%0.025 | 0 | 37.50%0.055 | 0.015 | 0 | 0.00%0.04 | 0 | 33.33%0.04 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.